Genomictree Inc. (KOSDAQ:228760)
South Korea flag South Korea · Delayed Price · Currency is KRW
11,180
-110 (-0.97%)
Sep 1, 2026, 3:30 PM KST

Genomictree Balance Sheet

Millions KRW. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
17,46916,31526,35045,26967,57266,461
Short-Term Investments
61,71261,05169,73047,87747,03364,081
Cash & Short-Term Investments
79,18177,36696,08093,146114,605130,542
Cash Growth
-8.16%-19.48%3.15%-18.72%-12.21%26.59%
Accounts Receivable
366.39384.04332.5388.291,0312,267
Other Receivables
729.72273.45274.54286.19144.1128.22
Receivables
1,096657.49607.04674.471,1752,295
Inventory
346.99265.3334.58496.53635.45284.87
Prepaid Expenses
41.0542.24105.9395.89424.22502.98
Other Current Assets
500.25574.12534.92657.951,160702.45
Total Current Assets
81,16578,90597,66295,371118,000134,327
Property, Plant & Equipment
17,53619,85818,38617,46017,86621,459
Long-Term Investments
17,43714,2316,43014,04821,13619,656
Other Intangible Assets
1,3031,2411,2501,3361,4701,523
Long-Term Deferred Charges
00020.9283.67146.43
Other Long-Term Assets
6,9676,5266,9474,6084,35440.12
Total Assets
124,409120,762130,675132,844162,910177,151

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Accounts Payable
125.2776.8966.8966.79132.687.57
Accrued Expenses
504.211,4981,4451,4331,821441.27
Short-Term Debt
-2,3011,9721,69029,043-
Current Portion of Long-Term Debt
--0000-
Current Portion of Leases
32.941.3247.4247.4252.8265.79
Current Income Taxes Payable
----1.7-
Current Unearned Revenue
-2.011.030.649.828.6
Other Current Liabilities
671.51524.591,2182,04422,3811,319
Total Current Liabilities
1,3344,4454,7515,28153,4422,142
Long-Term Debt
-----37,271
Long-Term Leases
11.0824.8159.9897.5284.63907.61
Pension & Post-Retirement Benefits
970.36854.71,4182,2901,2022,754
Long-Term Deferred Tax Liabilities
103.3103.392.9792.97579.61206.6
Other Long-Term Liabilities
58.524.5533.7849.9444.3918,770
Total Liabilities
2,4775,4526,3567,81255,35362,050

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Common Stock
12,43012,19112,18112,00610,51310,164
Additional Paid-In Capital
94,38886,31685,93579,97257,05055,819
Retained Earnings
7,79712,03720,60231,27439,97646,434
Treasury Stock
-4,118-4,714-4,878-4,984-4,984-
Comprehensive Income & Other
11,1469,23910,0456,4684,3452,296
Total Common Equity
121,644115,070123,885124,736106,900114,713
Minority Interest
287.68239.96434.79295.48502.28-
Shareholders' Equity
121,931115,310124,320125,032107,557115,101
Total Liabilities & Equity
124,409120,762130,675132,844162,910177,151

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Total Debt
43.982,3682,0791,83529,18038,444
Net Cash (Debt)
79,13774,99894,00191,31285,42592,098
Net Cash Growth
-5.79%-20.21%2.94%6.89%-7.25%0.57%
Net Cash Per Share
3271.483123.843937.193444.884069.684461.03
Filing Date Shares Outstanding
23.9324.0223.9923.6320.6520.33
Total Common Shares Outstanding
23.9324.0223.9923.6320.6520.33
Working Capital
79,83174,46092,91290,09064,557132,185
Book Value Per Share
5083.764790.105163.995278.295177.785643.25
Tangible Book Value
120,341113,829122,635123,400105,429113,190
Tangible Book Value Per Share
5029.304738.455111.895221.765106.575568.33
Land
7,7257,8557,6997,9817,9249,612
Buildings
5,8695,6225,7036,1676,1008,064
Machinery
7,39410,9468,7756,1026,0164,524
Construction In Progress
1,700326.11363.59326.11133.2138.2